Relating to insurance coverage for prescription insulin drugs

Sponsored by Sen. Tony Bisignano (D), Sen. Molly Donahue (D), Sen. William A. Dotzler Jr. (D), Sen. Sarah Trone Garriott (D), Sen. Janet Petersen (D), Sen. Art Staed (D), Sen. Thomas Townsend (D), Sen. Janice Weiner (D), Sen. Cindy Winckler (D)

Topics:Health care Insurance Prescription drug prices

Same legislation: HF 405

Write your legislators about it

Official bill page Lobbyist declarations One-pager to print

Where it is now

Done: IntroducedFebruary 4, 2025
Done: SubcommitteeFebruary 5, 2025
Stopped: Senate committeeDied when the General Assembly ended
Next: Passes the Senate
Next: House committeeFunnel: by March 20, 2026
Next: Passes the House
Next: To the Governor
Next: Signed into law

Died when the session ended The 2026 session adjourned on May 3, 2026, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?

What’s in it

AI summary Health insurance plans in Iowa would be required to limit how much people pay out-of-pocket for certain types of insulin. For a 31-day supply of covered insulin, the cost to the person would be capped at $25. This rule applies to various insurance policies and contracts starting in 2026.¹

Read the official explanation

This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. 209 required to pay per prescription filled of an insulin drug to an amount not more than $25 for an up to 31-day supply of at least one type of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs. “Prescription insulin drug” is defined in the bill as a prescription drug that contains insulin, is used to treat diabetes, has been prescribed as medically necessary by a covered person’s health care professional, and is a benefit covered by a covered person’s policy, contract, or plan. The bill defines “cost-sharing” as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense imposed on a covered person. The bill does not prohibit a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses from reducing a covered person’s cost-sharing to less than $25 for up to a 31-day supply of a prescription insulin drug. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2026, by the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. /mb 3/ 3

Full bill text²

Senate subcommittee

Named February 5, 2025. It hasn’t reported yet.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Iowa Code it changes

Creates§514C.18A

How the Code works³

Lobbying

3 for · 0 against · 2 undecided · Who →

Family tree

Tried before

SF 2214Cleared committee90th GA SF 2062Cleared committee90th GA HF 694Cleared committee90th GA HF 502Cleared committee90th GA

91st General Assembly

SF 209Cleared committeeSenate companion HF 405Cleared committeeHouse companion

Earlier and later bills are matched by wording or an identical title.

Tried before

This idea has been filed in 3 earlier General Assemblies. None became law, though one got through a chamber.

HF 502 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · In committee · same title
Cleared committee
HF 694 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · In committee · same title
Cleared committee
SF 2062 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · In committee · same title
Cleared committee
SF 2214 Relating to insurance coverage for prescription insulin drugs
90th General Assembly · Approved by committee · nearly identical
Cleared committee
HF 263 Relating to insurance coverage for prescription insulin drugs, and including applicability…
89th General Assembly · Passed House · nearly identical
Passed a chamber
HF 2511 Relating to prescription refills in emergency situations and insurance coverage for prescr…
89th General Assembly · In committee · similar
Cleared committee
SF 2113 Relating to insurance coverage for prescription insulin drugs
88th General Assembly · In committee · same title
Cleared committee
HF 2138 Relating to insurance coverage for prescription insulin drugs
88th General Assembly · Passed House · nearly identical
Passed a chamber

Similar bills this General Assembly

HF 658 Relating to insurance coverage for prescription insulin drugs
91st General Assembly · In committee
Nearly identical
SF 2047 Relating to insurance coverage for prescription insulin drugs
91st General Assembly · In committee
Nearly identical
SF 2322 Relating to insurance coverage for prescription insulin drugs
91st General Assembly · In committee
Nearly identical

Matched by wording or an identical title.